Celox Medical

What Celox Medical does

Celox Medical is a privately held med-tech company headquartered in Crewe, United Kingdom, with a regional office in New York serving North America via its OMNI-STAT brand. Trading under the legal entity Medtrade Products Limited (rebranded to CELOX Medical in February 2025), the company develops, manufactures, and distributes patented chitosan-based haemostatic and advanced wound care medical devices for military, emergency medical, hospital, and workplace safety markets. Its core technology platform is CELOX, a chitosan-based haemostatic composition extracted from shrimp shells that works independently of the body's natural clotting cascade, with derivative platforms including Chito-R (activated chitosan granules) and Multiflex (responsive hexagon foam dressings).

The product portfolio spans two segments. The pre-hospital segment includes haemorrhage control devices (CELOX Rapid, CELOX Gauze, CELOX Granules, CELOX-A applicator), respiration management (FOXSEAL and FOXSEAL Vented chest seals), burn treatment (Silvapro), and a magnetic-buckle tourniquet (MAG-TQ). The hospital segment includes the AVARUS family of silicone foam wound dressings (IV, Multiflex, Border Foam, Post Op) and OB-GYN-focused CELOX PPH for postpartum haemorrhage control. All CELOX products are Class III CE-marked, FDA 510(k) cleared, and EU MDR certified via BSI.

Revenue is generated through hardware sales to a global network of authorized distributors, with products deployed by the UK Ministry of Defence, US DoD (CoTCCC listed), NATO forces, hospital systems, EMS providers, and workplace safety customers. CEO Russ Mably has disclosed revenues of £45m, supported by LDC (Lloyds Banking Group) as investment partner. Go-to-market combines direct engagement for major tenders with distributor-led sales across military, EMS, hospital, and workplace segments; pricing is not publicly disclosed and is negotiated through authorized channel partners.

Name

Celox Medical

Legal name

Medtrade Products Limited

Website

https://celoxmedical.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Celox Medical is a UK-based med-tech company that develops, manufactures, and distributes patented chitosan-based haemostatic devices and advanced wound care dressings used by military forces, emergency medical services, hospitals, and workplace safety buyers worldwide.

Ownership category

akta.pro rank

Product category

Haemostatic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

akta.pro secondary industry

Medical & Hygiene Disposables (Underpads, Disposable Washcloths, Bed Bath Products) (CRADALAK)

Keywords

• Hemostatic medical devices
• Advanced wound care
• Haemorrhage control products
• Chitosan hemostatic technology
• Trauma care products

Headquarters

HQ city

Crewe

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: CELOX Medical generates revenue through the sale of medical devices including haemostatic products (CELOX Gauze, CELOX Rapid, CELOX Granules, CELOX-A Applicator), wound care products (AVARUS brand), and respiration management products (FOXSEAL chest seals). Products are sold through a global distributor network to military, emergency services, hospitals, and workplace safety markets.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Celox Medical is a global med-tech company that develops, manufactures and commercialises patented chitosan-based haemostatic medical devices and advanced wound care products. The portfolio includes haemostatic gauzes (CELOX Rapid, CELOX Gauze), granules and applicators (CELOX Granules, CELOX-A), tourniquets (MAG-TQ), chest seals (FOXSEAL, FOXSEAL Vented), burn dressings (Silvapro), silicone foam wound dressings (AVARUS IV, Multiflex, Border Foam, Post Op), and postpartum haemorrhage gauze (CELOX PPH). Products are sold worldwide to military, emergency medical, hospital and workplace safety markets through a global distributor network.

Product overview

Celox Medical is a global med-tech company that offers a portfolio of physical medical devices organized into two main segments: Pre-Hospital (hemorrhage control, respiration management, burn treatment) and Hospital (advanced wound care). The core technology platform is CELOX, a patented chitosan-based hemostatic technology used across hemostatic products including CELOX Rapid, CELOX Gauze, CELOX-A, CELOX Granules, and CELOX PPH. Additional product lines include MAG-TQ tourniquets, FOXSEAL chest seals (including Vented variant), and Silvapro burn dressings. The Hospital segment offers AVARUS branded advanced wound care products including IV, Multiflex, Border Foam, and Post Op dressings. OMNI-STAT products provide additional hospital hemostatic solutions. The company rebranded from Medtrade Products to CELOX Medical in February 2025.

Differentiator

Problem solved

Functional benefit

Brands

• CELOX: Patented haemostatic technology brand used for bleeding control products including CELOX Rapid, CELOX Gauze, CELOX Granules, and CELOX-A applicator.
• OMNI-STAT
• AVARUS
• MAG-TQ
• FOXSEAL
• Silvapro

Products and services

• CELOX Rapid Haemostatic gauze containing Chito-R activated chitosan granules that stop severe arterial bleeding with 60 seconds of compression; works independently of the body's natural clotting cascade and is effective in hypothermic conditions and on anticoagulated blood. Used by military, EMS, hospitals and first responders.
• CELOX-A Applicator Pre-filled applicator containing 6g of CELOX haemostatic granules designed to treat narrow penetrating injuries such as blast, knife, shrapnel or bullet entry wounds, reaching bleeding sites in seconds.
• CELOX Granules Loose haemostatic granules for stopping bleeding from irregularly shaped wounds and multiple injuries; clots blood containing anticoagulants such as heparin, warfarin and rivaroxaban.
• CELOX Gauze Haemostatic gauze recommended by the US CoTCCC and used by NATO forces for stopping bleeding from emergency life-threatening injuries; battlefield analysis linked it to statistically significant improvement in survival.
• MAG-TQ Arterial Tourniquet Arterial tourniquet featuring magnetic V-buckle technology for fast, easy and effective bleeding control; self-locking design enables application in under 10 seconds and includes H&L strap and precision-engineered aluminium windlass rod.
• FOXSEAL Chest Seal Occlusive chest seal for treatment of open chest wounds and prevention of pneumothorax; compact size fits an IFAK without folding and the pack contains two seals for entry and exit wounds.
• FOXSEAL Vented Chest Seal Vented chest seal with a unique 360° Hyper-Vent system and 512 vents that release pressure and prevent tension pneumothorax; uses a hydrogel base and re-seal tab for decompression.
• Silvapro Burn Dressing Antibacterial burn dressing combining chitosan and ionic silver to provide dual cooling and antibacterial protection for pre-hospital management of first and second degree burns.
• AVARUS IV CHG Foam Disc Chlorhexidine Gluconate (CHG) protective foam disc for vascular access sites; absorbs up to eight times its own weight in fluid and provides 7-day site protection to reduce catheter-related bloodstream infections.
• AVARUS Multiflex Dressing 5-layered soft silicone adhesive bordered foam dressing using patented Multiflex technology — a network of responsive hexagons that adapt to body shape and flex with movement for secure fixation and outstanding fluid handling.
• AVARUS Border Foam Dressing 5-layered silicone foam dressing designed for pressure injury prevention and management of partial and full thickness wounds with drainage, featuring market-leading pressure displacement and microclimate management.
• AVARUS Post Op Dressing Flexible fenestrated post-operative dressing for surgical wounds, abrasions and cuts; super absorbent pad locks fluid in the dressing and the dressing can be left in place for up to 7 days to support patient mobilisation.
• CELOX PPH (Postpartum Haemorrhage Gauze) Chitosan-covered gauze indicated for uterine packing to control postpartum haemorrhage; clinical evidence shows 95.7-100% successful haemostasis and a 77.8% reduction in hysterectomies versus standard of care.
• OMNI-STAT Hospital Haemostatic Products Haemostatic gauze and granules powered by CELOX technology for fast, safe and effective control of minor, moderate and severe bleeding in hospital settings; includes CELOX Vascular 2in x 2in pads for vascular access haemorrhage control.
• CELOX Rapid X-Ray Detectable (North America) Fastest-acting haemostatic gauze with an X-ray detectable strip for the North American market; stops severe arterial bleeding with 60 seconds of compression and can be left in place for up to 72 hours.
• CELOX EMS (North America) Versatile fast-acting haemostatic gauze pads for EMS providers in the North American market, available in 4x4 inch and 8x8 inch formats; works independently of the clotting cascade and recorded the highest observed survival rates in US DoD tests.
• CELOX First Aid Granules (North America) 2g haemostatic granules for stopping bleeding from minor cuts, lacerations and abrasions; FDA cleared for home, work, leisure and travel use in compact lightweight packaging.

Quantifiable outcome

• 100% haemostasis success rate in 84/84 cases with CELOX Rapid in real-world clinical use
• +8 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Committee to Protect Journalists (CPJ)coreStrategic or Co-development Partner · 9 May 2022Partnership between Committee to Protect Journalists and Medtrade (now CELOX Medical) to distribute CELOX lifesaving medical supplies in Ukraine. As the war in Ukraine entered its third month, journalists facing increased risks in their daily reporting received lifesaving medical supplies through this partnership. The collaboration aimed to protect journalists operating in conflict zones.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Z-Medica (QuikClot): Direct competitor in chitosan and kaolin-based hemostatic gauze; QuikClot Combat Gauze is the principal rival to CELOX in US DoD TCCC guidelines and is now owned by Teleflex, giving it distribution scale.
• HemCon Medical Technologies: Also a chitosan-based hemostatic gauze producer, originally spun out of Oregon Medical Laser Center. Most direct technology competitor to CELOX in the chitosan hemostatic chemistry space.

Broad incumbents

• Teleflex: Broader medical device incumbent owning QuikClot, Arrow, and other emergency/trauma product lines. Competes with CELOX in hemostatic gauze and overlaps in vascular access and emergency care markets.
• Integra LifeSciences: Diversified medical device company with a significant wound care and surgical instruments portfolio (Integra Dermal Regeneration Template, AmnioExcel). Competes with AVARUS advanced wound care line.
• Smith & Nephew: Global leader in advanced wound management (Allevyn, PICO) and sports medicine. AVARUS Multiflex and Post Op compete directly with Smith & Nephew's silicone foam dressing portfolio.
• Mölnlycke Health Care: Major advanced wound care company (Mepilex, Mepitel, Avance) and surgical solutions provider. Competes with AVARUS in hospital foam dressings and with CELOX in operating-room hemostasis.
• Convatec: Specialist in advanced wound care (Aquacel, Foam Lite) and ostomy care. Direct competitor in hospital wound dressings and overlaps with AVARUS Multiflex positioning.
• Baxter International: Major medical products company with hemostatic agents (Floseal, Tisseel) used in surgical settings. Overlaps with CELOX/OMNI-STAT in hospital hemostasis and competes via Baxter's surgical solutions franchise.
• Ethicon (Johnson & Johnson MedTech): Surgical franchise within J&J offering hemostatic products (Surgicel, Evicel) and wound closure devices. Competes with CELOX in operating-room bleeding control and overlaps in vascular access wound management.
• BD (Becton Dickinson): Global medical technology company with wound care, vascular access, and surgical instruments. Competes with AVARUS IV (CHG vascular access discs) and adjacent product lines in hospital vascular site management.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/CeloxMedical
• YouTubeyoutube.com/user/CeloxMedical
• Facebookfacebook.com/celoxmedical
• LinkedInlinkedin.com/company/celox-medical
• Instagraminstagram.com/celoxmedical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celox Medical